Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc

WHIPPANY, N.J., Aug. 5 /PRNewswire/ -- Nexgen Spine, a leading developer
of innovative spinal implants for the surgical treatment of degenerative disc
disease, announced today that it has received CE mark approval to market the
Physio-L(R) Lumbar Artificial Disc in the European Union.
"We are delighted that the Physio-L(R) Artificial Disc Prosthesis has
received CE mark approval," said Alastair Clemow, Ph.D., President and CEO of
Nexgen Spine. "This represents an important milestone in our plan to launch a
full range of artificial disc prostheses based on our proprietary elastomeric
disc technology." Dr. Clemow further added, "the fact that the Physio-L(R) is
the first of the next generation elastomeric lumbar discs to receive a CE mark
makes this approval even more exciting."
The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designed
to be used in the lumbar spine for patients suffering from degenerative disc
disease. The device's proprietary elastomeric technology enables the disc to
closely mimic the mechanical properties of the natural disc and represents a
significant advance over current designs of disc prostheses.
"The unique properties of the Physio-L(R) help restore the natural shock
absorption of the disc," said Casey Lee MD, Chairman and Founder of Nexgen
Spine. "This allows the surgeon to restore function to the patient's disc.
The clinical data for the Physio-L(R) are demonstrating outstanding
improvements in both patient disability and pain, supporting the concept of
using elastomeric polymers for total disc prostheses."
Nexgen Spine, Inc. is dedicated to providing its customers with high
quality products that promote pain relief, preservation of motion and
restoration of function by applying state-of-the-art design, biomaterials, and
manufacturing technology. The company, based in Whippany NJ, is ISO
13485:2003 certified.
Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302
(aclemow@nexgenspine.com)
SOURCE Nexgen Spine

Alastair Clemow, President & CEO of Nexgen Spine, Inc., +1-973-386-1800 ext
302, aclemow@nexgenspine.com